tiprankstipranks
Trending News
More News >
Telix Pharmaceuticals Ltd. (TLPPF)
OTHER OTC:TLPPF
US Market

Telix Pharmaceuticals Ltd. (TLPPF) Financial Statements

Compare
107 Followers

Telix Pharmaceuticals Ltd. Financial Overview

Telix Pharmaceuticals Ltd.'s market cap is currently $5.59B. The company's EPS TTM is $0.0389574; its P/E ratio is 162.25; Telix Pharmaceuticals Ltd. is scheduled to report earnings on February 20, 2025, and the estimated EPS forecast is $0.17. See an overview of income statement, balance sheet, and cash flow financials.
Dec 24Dec 23Dec 22Dec 21Dec 20
Income Statement
Total RevenueAU$ 783.21MAU$ 502.55MAU$ 160.10MAU$ 7.60MAU$ 5.21M
Gross ProfitAU$ 509.68MAU$ 314.39MAU$ 29.34MAU$ -29.77MAU$ -16.88M
Operating IncomeAU$ 82.13MAU$ 51.89MAU$ -73.18MAU$ -81.25MAU$ -49.25M
EBITDAAU$ 92.55MAU$ 22.97MAU$ -92.84MAU$ -70.07MAU$ -44.94M
Net IncomeAU$ 49.92MAU$ 5.21MAU$ -104.08MAU$ -80.51MAU$ -44.89M
Balance Sheet
Cash & Short-Term InvestmentsAU$ 710.35MAU$ 123.24MAU$ 116.33MAU$ 22.04MAU$ 77.94M
Total AssetsAU$ 1.52BAU$ 398.30MAU$ 260.59MAU$ 109.81MAU$ 164.44M
Total DebtAU$ 581.45MAU$ 17.45MAU$ 10.45MAU$ 2.54MAU$ 2.21M
Net DebtAU$ -128.90MAU$ -105.79MAU$ -105.88MAU$ -19.50MAU$ -75.74M
Total LiabilitiesAU$ 948.22MAU$ 249.39MAU$ 178.44MAU$ 106.17MAU$ 84.44M
Stockholders' EquityAU$ 568.21MAU$ 148.91MAU$ 80.01MAU$ 2.16MAU$ 79.02M
Cash Flow
Free Cash FlowAU$ 9.00MAU$ 13.09MAU$ -77.83MAU$ -60.67MAU$ 1.64M
Operating Cash FlowAU$ 43.03MAU$ 23.88MAU$ -63.97MAU$ -59.33MAU$ 1.96M
Investing Cash FlowAU$ -135.17MAU$ -25.49MAU$ -17.00MAU$ -2.73MAU$ -1.09M
Financing Cash FlowAU$ 638.92MAU$ 10.19MAU$ 174.96MAU$ 2.85MAU$ 34.12M
Currency in AUD

Telix Pharmaceuticals Ltd. Earnings and Revenue History

Telix Pharmaceuticals Ltd. Debt to Assets

Telix Pharmaceuticals Ltd. Cash Flow

Telix Pharmaceuticals Ltd. Forecast EPS vs Actual EPS

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis